Iguratimod ameliorates bleomycin‐induced alveolar inflammation and pulmonary fibrosis in mice by suppressing expression of matrix metalloproteinase‐9
Sign Up to like & getrecommendations! Published in 2019 at "International Journal of Rheumatic Diseases"
DOI: 10.1111/1756-185x.13463
Abstract: To investigate the potential therapeutic efficacy of iguratimod (IGU) on bleomycin (BLM)‐induced pulmonary fibrosis in mice. read more here.
Keywords: bleomycin induced; ameliorates bleomycin; pulmonary fibrosis; fibrosis mice ... See more keywords